Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68.49 CHF | -1.53% | -.--% | -.--% |
May. 29 | UBS Adjusts DuPont de Nemours Price Target to $98 From $93, Maintains Buy Rating | MT |
May. 28 | DuPont's Breakup Plan Holds Logic Amid Disadvantages, BofA Says | MT |
Evolution of the average Target Price on DuPont de Nemours, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering DuPont de Nemours, Inc.
UBS | |
Barclays | |
Citigroup | |
BofA Securities | |
Deutsche Bank Securities | |
Wells Fargo Securities | |
BMO Capital | |
Mizuho Securities | |
Jefferies & Co. | |
Morgan Stanley | |
RBC Capital Markets | |
JPMorgan Chase | |
DA Davidson | |
KeyBanc Capital Markets | |
Credit Suisse | |
Vertical Research | |
JPMORGAN | Stephen Tusa |
Goldman Sachs | |
J.P. Morgan Chase | |
DZ Bank | |
Exane BNP Paribas | |
Susquehanna | |
HSBC |
EPS Revisions
- Stock Market
- Equities
- DD Stock
- 6D81 Stock
- Consensus DuPont de Nemours, Inc.